Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 1/20 | 0.47 |
| ▸ | MMP9 | P14780 | 1/20 | 0.47 |
| ▸ | MMP13 | P45452 | 1/20 | 0.47 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | OPRL1 | P41146 | 2/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | HCRTR1 | O43613 | 2/20 | 0.44 |
| ▸ | HCRTR2 | O43614 | 2/20 | 0.44 |
| ▸ | ACHE | P22303 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12621872 | 0.84 | MCOLN3 (0.57) | KMT2AL3MBTL1 | |
| SCHEMBL13035959 | 0.80 | HCRTR1 (0.58) | KMT2AALDH1A1KDM4EL3MBTL1HCRTR1 | |
| SCHEMBL15426005 | 0.79 | HCRTR1 (0.52) | ALDH1A1L3MBTL1HCRTR1HCRTR2 | |
| SCHEMBL12663594 | 0.78 | L3MBTL1 (0.52) | ALDH1A1L3MBTL1HCRTR1HCRTR2 | |
| SCHEMBL12622076 | 0.78 | L3MBTL1 (0.52) | KMT2AALDH1A1L3MBTL1HCRTR1HCRTR2 | |
| SCHEMBL13035949 | 0.78 | L3MBTL1 (0.45) | ALDH1A1L3MBTL1HCRTR1HCRTR2 | |
| SCHEMBL12626207 | 0.78 | L3MBTL1 (0.61) | MMP1MMP9MMP13ADAM17ALDH1A1 | |
| SCHEMBL12626158 | 0.77 | LMNA (0.61) | MMP1MMP9MMP13ADAM17ALDH1A1 | |
| SCHEMBL12626379 | 0.76 | L3MBTL1 (0.46) | ALDH1A1KDM4EL3MBTL1HCRTR1HCRTR2 | |
| SCHEMBL12626027 | 0.76 | ALDH1A1 (0.49) | KMT2AALDH1A1L3MBTL1HCRTR1HCRTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8580808-B2 | Filamin A-binding anti-inflammatory analgesic | Pain Therapeutic, Inc. (US) | 2013-11-12 | — | — | US | disclosed |
| US-8580809-B2 | Filamin A-binding anti-inflammatory analgesic | PAIN THERAPEUTICS, INC. (US) | 2013-11-12 | — | — | US | disclosed |
| US-20110105484-A1 | FILAMIN A-BINDING ANTI-INFLAMMATORY ANALGESIC | PAIN THERAPEUTICS | 2011-05-05 | — | — | US | disclosed |
| US-20110105547-A1 | FILAMIN A-BINDING ANTI-INFLAMMATORY ANALGESIC | PAIN THERAPEUTICS | 2011-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110105484-A1 | FILAMIN A-BINDING ANTI-INFLAMMATORY ANALGESIC | FLNA, FLNB, OPRK1 | MMP1 2812/4885MMP9 1119/4885MMP13 1607/4885 |
| US-20110105547-A1 | FILAMIN A-BINDING ANTI-INFLAMMATORY ANALGESIC | FLNA, FLNB, OPRK1 | MMP1 2812/4885MMP9 1119/4885MMP13 1607/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.